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Surgical site infection (SSI) associated with instruments remains a serious 
and common complication in patients who undergo Total en bloc 
spondylectomy (TES). It is very important that the risk factors for SSI are 
known in order to prevent it. 
Purpose 
 To identify independent risk factors for SSI after TES and to evaluate the 
positive effect of iodine-supported spinal instruments in the prevention of 
SSI after TES. 
Study Design 






 One hundred twenty-five patients who underwent TES for vertebral tumor 
were evaluated. 
Outcome Measures 
 Incidence rate of SSI, Risk factors for SSI after TES, Safety of 
iodine-supported spinal instrumenst. 
Methods 
Risk factors for SSI were analyzed using logistic regression. In recent 69 
patients with iodine-supported spinal instruments, the thyroid hormone 
levels in the blood were examined to confirm if iodine from the implant 
influenced thyroid function. Postoperative radiological evaluations were 
performed regularly. 
Results 
 The rate of SSI was 6.4% (8/125 patients). By multivariate logistic 
regression, combined anterior and posterior approach and non-use of 
iodine-supported spinal instruments were associated with an increased risk 
of SSI. The rate of SSI without iodine-supported spinal instruments was 
12.5%, whereas the rate with iodine-supported spinal instruments was 1.4%. 
This difference was statistically significant. There were no detected 
abnormalities of thyroid gland function with the use of iodine-supported 
instruments. Among the 69 patients with iodine-supported spinal 





failure. However, there were no obvious involvements with the use of 
iodine-supported spinal instruments. 
Conclusions 
 This study identified combined anterior and posterior approach, and 
non-use of iodine-supported spinal instruments to be independent risk 
factors for SSI after TES. Iodine-supported spinal instrument was extremely 
effective for prevention of SSI in patients with compromised status, and it 







 We have performed total en bloc spondylectomy (TES) for vertebral tumor 
to avoid recurrence and to control spinal paralysis with good clinical outcome 
[1-3]. TES is a large invasive surgical procedure and is technically 
demanding; thus, it has potential risks of perioperative systemic 
complications. In addition, patients with vertebral tumor might have poor 
nutritional status and are prone to immunosuppression from the effect of the 
disease or treatments. Patients treated by TES are, therefore, likely to 
surgical site infection (SSI) as one of the serious complications, and SSI may 
compromise the quality of treatment outcome. Jansson et al [4] reported that 
the rate of complications was 56 (20%) of 282 cases with neurological deficit 
due to spinal metastases. Of the 56 cases, wound infections were seen in 34 
(11.3%). Demura et al [5] reported that the incidence of SSI was 7 (31.8%) of 
22 cases with prior irradiation in spinal metastases. However, the incidence 
of SSI significantly decreased to 4.5% (1/22 cases) by administering 
prostaglandin E1 (PGE1) in cases treated with prior irradiation. Hence, we 
have used PGE1 to prevent SSI in all patients treated by TES from April 
2006. 
 Recently, we developed a new procedure for anodization of 
iodine-containing surfaces that could be directly supported to existing 
titanium implants. In a basic study using Japanese white rabbits, the results 





biocompatibility, and no cytotoxicity [6]. Based on the above facts, we have 
performed clinical trials in spinal operation using iodine-supported spinal 
instruments since November 2008. Therefore, the objectives of this study are 
to identify independent risk factors for SSI after TES and to evaluate the 
positive effect of iodine-supported spinal instruments in the prevention of 
SSI after TES.  
 
Materials and Methods 
Patients 
 One hundred twenty-five patients who underwent TES for vertebral tumor 
between April 2006 and June 2013 were evaluated. There were 63 males and 
62 females, with a median age of 53.8 years (range, 16-77 years). Of the 125 
patients, 18 patients had primary vertebral tumors and 107 with metastatic 
tumors. The histology of primary vertebral tumors included giant cell tumor 
in 9 patients, symptomatic hemangioma in 2, and others in 7 patients. The 
histology of metastatic vertebral tumors was comprised of kidney cancer in 
29 patients, breast cancer in 15, thyroid cancer in 13, lung cancer in 9, 
leiomyosarcoma in 5, chondrosarcoma in 3, bladder cancer in 2, colon cancer 
in 2, liver cancer in 2, rectal cancer in 2, chordoma in 2, liposarcoma in 2, 
osteosarcoma in 2, unknown in 4, and others in 15 patients. In addition, 69 
patients were treated with iodine-supported spinal instruments, whereas 





patients with and without iodine-supported spinal instruments. 
Outcome measure 
 In this study, we evaluated the incidence of SSI and its association with 
the following 15 parameters: age (< 60 or ≥ 60 years), gender, body mass 
index (< 25 or ≥ 25 kg/m2), smoking status, diabetes, nutrition (albumin <3.5 
or ≥ 3.5 g/dL), prior irradiation, preoperative chemotherapy (within 3 
months), tumor histology (primary or metastasis), previous surgery at 
surgical site, operation time (< 600 or ≥ 600 minutes), intraoperative blood 
loss (< 1000 or ≥ 1000 ml), surgical approach (posterior only or combined 
anterior and posterior), number of resected vertebrae (< 2 or ≥ 2), and with or 
without iodine-supported spinal instruments. 
In recent 69 patients with iodine-supported spinal instruments, 
thyroid-stimulating hormone (TSH), free triiodothyronine (FT3), and free 
thyroxine (FT4) were examined to confirm if iodine from the implant 
influenced thyroid function. Blood samplings were conducted before surgery 
and at 1 month after surgery. Postoperative radiological evaluations were 
performed regularly; wherein, loosening and failure of the instruments were 
checked. In these patients, the mean follow-up period was 14.0 months 
(range, 2-37 months). This study was approved by the ethics committee of 
Kanazawa University. Written informed consent was obtained from 69 






Univariate methods were used to detect differences between the incidence 
of SSI and risk factors. Contingency tables were used to assess association 
using Fisher exact tests. Statistical significance was set at a P value of less 
than 0.05. For multivariate analysis, multivariable stepwise logistic 
regression was used to identify independent risk factors for SSI. The 
variables with univariate P values of less than 0.2 were considered as 
candidates for multiple logistic regression. SPSS statistical software version 
19 (SPSS, Inc., Chicago, Illinois) was used to perform the statistical analysis. 
 
Results 
Incidence of SSI 
 During the period of this study, the incidence of SSI was 6.4% (8/125 
patients). Among the 8 patients, 1 was involved with iodine-supported spinal 
instruments while the rest of the 7 patients were not. Microorganisms 
isolated from the SSI were Methicillin-resistant Staphylococcus aureus in 4 
patients, coagulase-negative Staphylococcus in 2, Enterococcus faecalis in 1, 
and Escherichia coli in 1 patient (Table 2). All patients were complicated by 
SSI within 1 month and classified as having deep SSI, and 4 of the 7 patients 
without iodine-supported spinal instruments underwent revision surgery 
because the antibiotics were not effective. On the other hand, antibiotics 
worked on the sole infected patient with iodine-supported spinal 





rate after TES was 91.2% at 1 year in this study. 
Risk factors for SSI 
The results of the univariate analysis of risk factors are shown in Tables 3 
and 4. Operation time (≥ 600 minutes), surgical approach (combined anterior 
and posterior approach), and spinal instruments (without iodine-supported 
spinal instruments) were significant risk factors for SSI after TES. In this 
study, both univariate analysis and multivariate analysis were used to 
evaluate potential risk factors. Stepwise regression analysis included the 3 
significant factors (P < 0.05) and 3 factors that were relatively large, with P 
values of less than 0.2 by univariate analysis. These 6 factors were age, 
tumor histology, previous surgery at surgical site, operation time, surgical 
approach, and spinal instruments. Only surgical approach was the 
significant independent risk factor by multivariate logistic regression. 
Combined anterior and posterior approach was significantly associated with 
an increased risk of SSI, with an adjusted odds ratio (OR) of 11.6 (95% 
confidence interval [CI], 2.21 - 61.26). Among the 5 factors with the exception 
of surgical approach, the multivariate analysis results demonstrated that 
spinal instrument was the significant risk factor for SSI. The use of 
iodine-supported spinal instruments was significantly associated with a 







Safety of Iodine-supported Spinal Instruments 
 The TSH levels (μIU/ml), FT3 levels (pg/ml) and FT4 levels (ng/dl) were 
within the normal range. (Figure 1). There were no detected abnormalities of 
thyroid gland function with the use of iodine-supported instruments. None of 
the implants loosened during the follow-up period. However, among the 69 
patients with iodine-supported spinal instruments, 2 patients (2.9%) 
required additional surgery due to instrument failure. One patient required 
revision surgery due to breakage of instruments caused by subsidence of 
cage at 12 months after the initial surgery. Another patient developed 
instrument failure due to a new metastatic tumor of the adjacent vertebra at 
21 months after the initial surgery, and revision TES was subsequently 
performed. On the other hand, in the other 56 patients without 
iodine-supported spinal instrument, 4 patients (7.1%) required additional 
surgery due to instrument failure. 
 
Discussion 
 SSI associated with instruments remains a serious and common 
complication in spinal surgery. For the patients who undergo a major 
surgery, such as TES, SSI is a more serious complication [7, 8]. Thus, it is 
very important that the risk factors for SSI are known in order to prevent it.  
 Several risk factors for SSI in spinal metastasis have been identified. Xu et 





with metastatic spinal tumors who underwent thoracic vertebrectomy via 
anterior, posterior, or combined approaches. In their study, the posterior 
approach was associated with the highest incidence of wound infection 
compared with anterior and combined approaches. Sundaresan et al [10] 
reported that wound breakdown and infection occurred in 11 (14%) of 80 
cases with spinal metastases. Major risk factors for the surgery of spinal 
metastases were age over 65 years, paraparesis, and prior use of radiation, 
chemotherapy, or both. In our previous study (Demura et al [5]), prior 
irradiation was the significant independent risk factor by multivariate 
logistic regression. In the current study, however, prior irradiation was not a 
significant risk factor. Among the 15 risk factors for SSI, operation time over 
10 hours, combined anterior and posterior approach, and non-use of 
iodine-supported spinal instruments were associated with a high incidence of 
SSI by univariate analysis in this study. By multivariate logistic regression, 
combined anterior and posterior approach and non-use of iodine-supported 
spinal instruments were associated with an increased risk of SSI. 
 Few reports have been published regarding the difference in infection rate 
by surgical approaches in patients with spinal metastases. Xu [9] and Quan 
[11] and their colleagues reported that the posterior approach was associated 
with the highest incidence of SSI compared with other approaches. 
Conversely, the combined anterior and posterior approach was significantly 





disadvantages of the combined anterior and posterior approach are the need 
for patient repositioning and possibly a staged procedure, increased 
operative time, and extent of surgical trauma. In addition, more extensive 
invasion is needed in patients with history of previous surgery. Thus, we 
think that the rate of SSI is high in patients with combined anterior and 
posterior approach. On the other hand, there are several studies that 
describe the benefit of combined anterior and posterior 
approach. Roy-Camille et al [12] have suggested that a 2-stage operation is 
required at the lumbar level because both the psoas and iliac muscles have 
insertions on the vertebral body, as well as the vascular lumbar pedicles, 
which makes the posterior single approach impossible. Kawahara et al [13] 
reported that complete en bloc excision of the spinal tumor at L4 or L5 (while 
preserving the lumbar nerves) could be safely achieved through gentle 
dissection of the lumbar nerve roots, surrounding musculatures, and major 
vessels in a combined posterior-anterior approach. Therefore, it is necessary 
to select the surgical approaches based on risk-benefit assessment. 
 In case of spinal metastases, the rate of SSI is reported from 6.8% to 20% [4, 
5, 9, 10, 14]. Similarly, the rate of SSI without iodine-supported spinal 
instruments was 12.5% (7/56 cases) in this study. On the other hand, the use 
of iodine-supported spinal instruments revealed a lower rate at 1.4% (1/69 
cases). Moreover, it is notable that the patient with SSI even with the use of 





instruments. It is usually difficult to cure infections without removing the 
instruments if an instrument-associated infection arises. Our results suggest 
that iodine-supported spinal instruments can be very effective in the 
prevention of SSI after TES. The antibacterial spectrum of iodine is very 
broad. The antimicrobial effect acts not only on general bacteria but also on 
viruses, tubercle bacilli, and even fungi. In addition, iodine does not cause 
drug resistance as induced by the administration of antibiotics [15]. By 
application of these advantages, the results of this study acquired good 
clinical outcome.  
 In order to reduce the incidence of implant-associated infections, several 
biomaterial surface treatments have been proposed [16-18]. There have also 
been reports on antibacterial alloy implants [19]. In particular, silver has 
attracted the interest of many investigators because of its good antimicrobial 
action and low toxicity, although some toxicity against human cells have 
been observed [20]. In our opinion, therefore, safety of silver-coated implants 
is unestablished. On the other hand, iodine is a trace metal and an essential 
component of the thyroid hormone. If iodine is released from the instrument, 
it is biologically safe because it can be excreted by the kidneys. In this study, 
the TSH, FT3, and FT4 levels were within the normal range during the 






 Mechanical strength is another factor necessary for the spinal instruments. 
There is no problem concerning the mechanical strength of iodine-supported 
spinal instruments because this is simply anodized titanium, and titanium is 
widely used for implants [6]. In this study, among the 69 patients with 
iodine-supported spinal instruments, 2 patients required additional surgery 
due to instrument failure. However, there was no obvious relationships 
between these events and the use of iodine-supported spinal instruments.  
The current study has several limitations, including the retrospective 
design, small sample size, and diversity of patient background. Therefore, a 
prospective randomized clinical trial on a large scale is necessary to 
demonstrate the statistical significance of the infection rate. Although the 
small patient size limits the significance of the current study, the positive 
effect of iodine-supported spinal instruments to prevent of SSI after TES is 
encouraging and warrants merits. 
 In conclusion, combined anterior and posterior approach and non-use of 
iodine-supported spinal instruments were associated with an increased risk 
of SSI after TES. Iodine-supported spinal instruments were effective for 
prevention of SSI in patients with compromised status. Moreover, this 
clinical trial of iodine-supported spinal instruments was performed with no 








[1] Kawahara N, Tomita K, Murakami H, Demura S. Total en bloc 
spondylectomy for spinal tumors: surgical techniques and related basic 
background. Orthop Clin North Am 2009;40:47-63. 
[2] Murakami H, Kawahara N, Demura S, Kato S, Yoshioka K, Tomita K. 
Neurological function after total en bloc spondylectomy for thoracic spinal 
tumors. J Neurosurg Spine 2010;12:253-6. 
[3] Tomita K, Kawahara N, Murakami H, Demura S. Total en bloc 
spondylectomy for spinal tumors: improvement of the technique and its 
associated basic background. J Orthop Sci 2006;11:3-12.  
[4] Jansson KA, Bauer HC. Survival, complications and outcome in 282 
patients operated for neurological deficit due to thoracic or lumbar spinal 
metastases. Eur Spine J 2006;15:196-202. 
[5] Demura S, Kawahara N, Murakami H, et al. Surgical site infection in 
spinal metastasis: risk factors and countermeasures. Spine 
2009;34:635-9. 
[6] Shirai T, Shimizu T, Ohtani K, Zen Y, Takaya M, Tsuchiya H. 
Antibacterial iodine-supported titanium implants. Acta Biomaterialia 
2011;7:1928-33. 
[7] Casadei R, Mavrogenis AF, De Paolis M, Ruggieri P. Two-stage, combined, 
three-level en bloc spondylectomy for a recurrent post-radiation sarcoma 





[8] Matsumoto M, Ishii K, Takaishi H, et al. Extensive total spondylectomy 
for recurrent giant cell tumor in the thoracic spine. J Neurosurg Spine 
2007;6:600-5. 
[9] Xu R, Garcés-Ambrossi GL, McGirt MJ, et al. Thoracic vertebrectomy and 
spinal reconstruction via anterior, posterior, or combined approaches: 
clinical outcomes in 91 consecutive patients with metastatic spinal 
tumors. J Neurosurg Spine 2009;11:272-84. 
[10] Sundaresan N, Rothman A, Manhart K, Kelliher K. Surgery for 
solitary metastases of the spine: rationale and results of treatment. Spine 
2002;27:1802-6. 
[11] Quan GM, Vital JM, Aurouer N, et al. Surgery improves pain, 
function and quality of life in patients with spinal metastases: a 
prospective study on 118 patients. Eur Spine J 2011;20:1970-8. 
[12] Roy-Camille R, Mazel CH, Saillant G, et al. Treatment of malignant 
tumors of the spine with posterior instrumentation. In: Sundaresan N, 
Schmidekm HH, Schiller AL, et al, eds. Tumors of the Spine. 
Philadelphia, PA: WB Saunders;1990:474-87. 
[13] Kawahara N, Tomita K, Murakami H, Demura S, Yoshioka K, Kato 
S. Total en bloc spondylectomy of the lower lumbar spine: a surgical 





[14] Finkelstein JA, Zaveri G, Wai E, Vidmar M, Kreder H, Chow E. A 
population-based study of surgery for spinal metastases. Survival rates 
and complications. J Bone Joint Surg Br 2003;85:1045-50  
[15] Tsuchiya H, Shirai T, Nishida H, et al. Innovative antimicrobial 
coating of titanium implants with iodine. J Orthop Sci 2012;17:595-604. 
[16] Ewald A, Gluckermann SK, Thull R, Gbureck U. Antimicrobial 
titanium/silver PVD coatings on titanium. Biomed Eng Online 2006;5:22. 
[17] Gosheger G, Hardes J, Ahrens H, et al. Silver-coated 
megaendoprostheses in a rabbit model-an analysis of the infection rate 
and toxicological side effects. Biomaterials 2004;25:5547-56.  
[18] Harris LG, Mead L, Muller-Oberlander E, Richards RG. Bacteria 
and cell cytocompatibility studies on coated medical grade titanium 
surfaces. J Biomed Mater Res A 2006;78:50-8.  
[19] Shirai T, Tsuchiya H, Shimizu T, Ohtani K, Zen Y, Tomita K. 
Prevention of pin tract infection with titanium-copper alloys. J Biomed 
Mater Res B Appl Biomater 2009;91:373-80. 
[20] Massè A, Bruno A, Bosetti M, Biasibetti A, Cannas M, Gallinaro P. 
Prevention of pin track infection in external fixation with silver coated 








Figure 1. Thyroid hormone levels: TSH levels (lIU/ml), FT3 levels (pg/ml), 
and FT4 levels (ng/dl) were within the normal range. 
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Table 1. Comparison of Patient Characteristics with and without 
Iodine-supported Instruments 
 
 Iodine-supported instruments 
W/ (69) W/O (56) 
Age 55.1 (16-73) 52.1 (19-77) 
Gender (male/female) 38/31 25/31 
Diabetes 10 (14.5%) 6 (10.7%) 
Irradiation 23 (33.3%) 12 (21.4%) 
Chemotherapy 33 (47.8%) 12 (21.4%) 
Tumor histology  
(Primary/Metastasis) 3/66 15/41 
Operation time 480±137 594±155 
Intraoperative blood loss 672±831 1140±842 
Surgical approach 
(Posterior only/Combined anterior and posterior) 58/11 37/19 
 
  
Table 2. Types of Organisms Cultured From Postoperative Infections 
 
     Organism No. of cases 
W/ iodine-supported instruments  
     Methicillin-resistant Staphylococcus aureus 1 
W/O iodine-supported instruments  
     Methicillin-resistant Staphylococcus aureus 3 
     coagulase-negative Staphylococcus 2 
     Enterococcus faecalis 1 
     Escherichia coli 1 
Incidence of SSI 8/125 (6.4%) 
 
  
Table 3. Univariate Analysis of Patient Characteristics 
 
Factor No. (%) with SSI 95% CI P 
Age   0.116 
   < 60 






Gender   0.632 
   Male 






BMI   0.355 
   < 25 






Smoking   0.336 
   Yes 




Diabetes   0.323 
   Yes 




Nutrition   0.324 
   Alb < 3.5 






Irradiation   0.397 
   Yes 




Chemotherapy   0.601 
   Yes 




Tumor histology   0.089 
   Primary 






Previous surgery   0.195 
   Yes 




The P values were calculated with Fisher exact test. 
  
Table 4. Univariate Analysis of Surgery-Related Characteristics 
 
Factor No. (%) with SSI 95% CI P 
Operation time   0.03* 
   < 600 






Intraoperative blood loss   0.666 
   < 1000 






Surgical approach   0.002* 
   Posterior only 






Number of resected vertebrae   0.596 
   < 2 






Spinal instruments   0.015* 
   W/ iodine-supported instruments  




The P values were calculated with Fisher exact test.              *Significant values (< 0.05) 
 
  
Table 5. Multivariate Analysis Results 
 
Factor Adjusted OR 95% CI P 
Surgical approach 11.6 2.21-61.26 0.004* 
Of the 6 factors, only surgical approach was the significant independent risk factor by 
multivariate logistic regression.    
Spinal instruments 0.1 0.01-0.86 0.036* 
Among the 5 factors with the exception of surgical approach, the multivariate analysis 
results demonstrated that spinal instrument was the significant risk factor for SSI. 
*Significant values (< 0.05)    
 

